View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Hoa Sen Group: 1 director

A director at Hoa Sen Group sold 390,900 shares at 0.000VND and the significance rating of the trade was 81/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...

 PRESS RELEASE

Webuy Announces Filing of 2023 Annual Report with the SEC, Launches Tr...

Webuy Announces Filing of 2023 Annual Report with the SEC, Launches Travel Business in Indonesia, and Expands into Insurance Referral Program Singapore, April 19, 2024 (GLOBE NEWSWIRE) -- Webuy Global Ltd (NASDAQ: WBUY) ("Webuy" or the "Company"), a Southeast Asian community e-commerce retailer, today announces that on April 15, 2024, the Company filed its 2023 annual report (20-F) with the SEC. Notable recent events include the Company’s launch of a travel business line in Indonesia and expansion into an insurance referral program. Key highlights of the Company’s 2023 financial achievem...

 PRESS RELEASE

SL Green Realty Corp. Announces Common Stock Dividend

SL Green Realty Corp. Announces Common Stock Dividend NEW YORK, April 19, 2024 (GLOBE NEWSWIRE) -- SL Green Realty Corp. (NYSE:SLG), Manhattan’s largest office landlord, today announced that its board of directors has declared a monthly ordinary dividend of $0.25 per share of common stock, which is the equivalent of an annualized dividend of $3.00 per share. The dividend is payable in cash on May 15, 2024 to shareholders of record at the close of business on April 30, 2024. About SL Green Realty Corp. SL Green Realty Corp., Manhattan's largest office landlord, is a fully integrated real...

 PRESS RELEASE

Huize Partners with PICC Life Insurance to Launch “i Wu You – Low-Thre...

Huize Partners with PICC Life Insurance to Launch “i Wu You – Low-Threshold Edition” – A Customized Critical Illness Insurance Product SHENZHEN, China, April 19, 2024 (GLOBE NEWSWIRE) -- Huize Holding Limited, (“Huize”, the “Company” or “we”) (NASDAQ: HUIZ), a leading insurance technology platform connecting consumers, insurance carriers and distribution partners digitally through data-driven and AI-powered solutions in China, today announced that it has partnered with PICC Life Insurance Company Limited (“PICC Life”) to launch “i Wu You – Low-Threshold Edition”, the latest customized cri...

 PRESS RELEASE

Perella Weinberg to Announce First Quarter 2024 Financial Results and ...

Perella Weinberg to Announce First Quarter 2024 Financial Results and to Host Conference Call on May 3, 2024 NEW YORK, April 19, 2024 (GLOBE NEWSWIRE) -- Perella Weinberg Partners (“PWP”) (NASDAQ:PWP), a leading global independent advisory firm, today announced that it plans to release its financial results for the first quarter 2024 on Friday, May 3, 2024, before the market opens. Conference Call and WebcastManagement will host a conference call and webcast to review PWP’s results on the same day at 9:00AM ET. A webcast of the conference call will be available to the public on a listen-...

Piraeus Bank S.A.: Key facts and statistics - 2023

A summary company profile, detailing Piraeus Bank S.A.’s business operations and financial highlights.

Melco International Development: 1 director

A director at Melco International Development bought 500,000 shares at 5.524HKD and the significance rating of the trade was 56/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last...

 PRESS RELEASE

Netcompany - Final transactions in connection with share buyback progr...

Netcompany - Final transactions in connection with share buyback programme Company announcement No. 17/2024                                                  19 April 2024 Final transactions in connection with share buyback programmeOn 25 January 2024, Netcompany Group A/S (“Netcompany”) announced that a share buyback programme of up to DKK 150m and a maximum of 1,300,000 shares had been initiated with the purpose of initiating the redistribution of DKK 2bn to shareholders in line with the midterm 2026 targets. The share buyback programme is executed in accordance with EU Marke...

Moody's Ratings affirms KB Insurance’s A2 IFSR; outlook stable

Hong Kong , April 19, 2024 – Moody's Ratings (Moody's) has affirmed the A2 insurance financial strength rating (IFSR) of KB Insurance Co., Ltd. (KB Insurance) and maintained the stable outlook. The affirmation of KB Insurance's A2 IFSR reflects its well-established market position as one of the top ...

 PRESS RELEASE

Middlefield Canadian Income PCC: Net Asset Value(s)

Middlefield Canadian Income PCC: Net Asset Value(s) Middlefield Canadian Income PCC Net Asset Value Middlefield Canadian Income PCC Middlefield Canadian Income - GBP PC (a protected cell company incorporated in Jersey with registration number 93546)Legal Entity Identifier: 2138007ENW3JEJXC8658 Net Asset Value As at the close of business on 18 April 2024 the estimated unaudited Net Asset Value per share was 119.09 pence (including accrued income, which excludes an amount of 1.325 pence per share in respect of the quarterly dividend to be paid on 30 April 2024). Investments in...

 PRESS RELEASE

Ocugen Announces Dosing Completion of Subjects with Geographic Atrophy...

Ocugen Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 2 of Phase 1/2 ArMaDa Clinical Trial of OCU410—A Modifier Gene Therapy MALVERN, Pa., April 19, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that dosing is complete in the second cohort of its Phase 1/2 ArMaDa clinical trial for OCU410 (AAV-hRORA)—a modifier gene therapy candidate being developed for geographic atrophy (GA), an advanced...

Synlab AG: 5 directors

Five Directors at Synlab AG sold 12,104,156 shares at 10.000EUR. The significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...

BTS Group Holding PCL: 1 director

A director at BTS Group Holding PCL bought 5,000,000 shares at 6.000THB and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two yea...

Want Want China Holdings Ltd: 1 director

A director at Want Want China Holdings Ltd bought 10,990,000 shares at 4.391HKD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last...

 PRESS RELEASE

Huize Holding Limited Files 2023 Annual Report on Form 20-F

Huize Holding Limited Files 2023 Annual Report on Form 20-F SHENZHEN, China, April 19, 2024 (GLOBE NEWSWIRE) -- Huize Holding Limited, (“Huize,” the “Company” or “we”) (NASDAQ: HUIZ), a leading insurance technology platform connecting consumers, insurance carriers and distribution partners digitally through data-driven and AI-powered solutions in China, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 with the U.S. Securities and Exchange Commission (the “SEC”) on April 19, 2024. The annual report can be accessed on the SEC’s we...

 PRESS RELEASE

The deadline for Valoe’s restructuring programme extended until 14.6.2...

The deadline for Valoe’s restructuring programme extended until 14.6.2024. Valoe has secured financing for the duration of the proceedings and continues to negotiate longer-term financing. Valoe Corporation        Stock Exchange Release        19 April 2024 at 14.05 Finnish time                                                          The deadline for Valoe’s restructuring programme extended until 14.6.2024. Valoe has secured financing for the duration of the proceedings and continues to negotiate longer-term financing. Valoe Corporation's ("the Company") restructuring proceedings comme...

 PRESS RELEASE

ProQR Achieves Successful Defense of New Challenge to its Axiomer™ IP ...

ProQR Achieves Successful Defense of New Challenge to its Axiomer™ IP Portfolio LEIDEN, Netherlands & CAMBRIDGE, Mass., April 19, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies, today announced it has again successfully defended against opposition filed against a key patent for its ADAR-mediated RNA editing platform Axiomer™. The opposition was filed in June 2021 with the European Patent Office (EPO) by a strawman against ProQR’s granted patent , which relates to editing oligonucleotide...

 PRESS RELEASE

Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2024

Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2024 The Annual General Meeting of Hofseth BioCare ASA for 2024 will be held at the company's premises at Keiser Wilhelms gate 24, 6003 Ålesund, on 10 May 2024 at 13:00 CET. The notice of the Annual General Meeting is attached. For further information, please contact: Jon Olav Ødegård, CEO of Hofseth BioCare ASA Phone: E-mail: About Hofseth BioCare ASA: HBC is a Norwegian consumer and pet health ingredient supplier and an incubator for new pharmaceutical drug leads.  Research is ongoing to identify the individual e...

 PRESS RELEASE

American Express First-Quarter Revenue Increased 11% to $15.8 Billion ...

NEW YORK--(BUSINESS WIRE)-- American Express Company (NYSE: AXP) today reported first-quarter net income of $2.4 billion, or $3.33 per share, compared with net income of $1.8 billion, or $2.40 per share, a year ago. (Millions, except per share amounts, and where indicated)   Quarters Ended March 31, Percentage Inc/(Dec) 2024 2023 Billed Business (Billions) FX-adjusted1 $367.0   $345.5 $344.1 6% 7% Total Revenues Net of Interest Expense FX-adjusted1 $15,801   $14,281 $14,230 1...

 PRESS RELEASE

Tiziana Life Sciences Announces Study Results from Intranasal Anti-CD3...

Tiziana Life Sciences Announces Study Results from Intranasal Anti-CD3 Foralumab in Multiple Sclerosis Patients with PIRA Highlighted in Neurology Today® - Intranasal foralumab attenuated microglial activation in patients with non-active secondary progressive multiple sclerosis and progression independent of relapse (PIRA) -- Data presented in a platform session at the Annual Meeting of the American Academy of Neurology in Denver, Colorado - NEW YORK, April 19, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company develo...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch